Biogen has a storied history. So why have investors soured? https://t.co/RsIokDnb9A— STAT (@statnews) May 2, 2018
Our website has launched with a fresh design for easier access to the answers you need. If you have questions about #inhaledinsulin, visit https://t.co/2x7No72zWV (See Safety Info: https://t.co/lEEe68xBCF) #Afrezza #diabetes #insulin #t1d #t2d #doc #pwd pic.twitter.com/HaW2tH32c2— AFREZZA® (@AfrezzaUS) April 30, 2018
Abbott CEO: "Globally, [Libre] has more than 650,000 users, White said. The product is adding 50,000 users a month and @AbbottGlobal estimates that there will be more than a million users globally by year's end." https://t.co/GW1OgCkMHS via @TheStreet— Bigfoot Biomedical (@BigfootBiomed) April 23, 2018
Can Instagram be the pharmaceutical industry's new best friend? This post is by no means a case study, but there are certain sets of patients who actively seek out better treatment options, and patients with Diabetes are at the top of this unscientific...